Clinical Trial Update: Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a gene therapy approach to prevent progression to cancer in premalignant lesions of the lip and oral cavity or oropharynx; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lip and Oral Cavity Cancer
• Oropharyngeal Cancer
• Tongue Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lip and Oral Cavity Cancer, Oropharyngeal Cancer | Phase 1, Phase 2 | Status: COMPLETED